# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
1650, Journal, 0, 13, "Ophthalmology", "", "<http://ctro/data#Publication_3702> <http://ctro/data#hasJournal> \"Ophthalmology\"."
1663, PublicationYear, 16, 20, "1999", "", "<http://ctro/data#Publication_3702> <http://ctro/data#hasPublicationYear> \"1999\"."
1670, Title, 49, 158, "A 12 - month , randomized , double - masked study comparing latanoprost with timolol in pigmentary glaucoma .", "", "<http://ctro/data#Publication_3702> <http://ctro/data#hasTitle> \"A 12 - month , randomized , double - masked study comparing latanoprost with timolol in pigmentary glaucoma .\"."
1665, Duration, 51, 61, "12 - month", "", "<http://ctro/data#ClinicalTrial_3712> <http://ctro/data#hasCTduration> \"12 - month\"."
1652, Randomized, 64, 74, "randomized", "", "<http://ctro/data#ClinicalTrial_3712> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
1653, DoubleBlind, 77, 92, "double - masked", "", "<http://ctro/data#ClinicalTrial_3712> <http://ctro/data#hasCTDesign> <http://ctro/data#DoubleBlind>."
1666, Latanoprost, 109, 120, "latanoprost", "", 
1667, Timolol, 126, 133, "timolol", "", 
1668, PigmentaryGlaucoma, 137, 156, "pigmentary glaucoma", "", "<http://ctro/data#ClinicalTrial_3712> <http://ctro/data#analysesHealthCondition> <http://ctro/data#PigmentaryGlaucoma>."
1658, Author, 159, 173, "Mastropasqua L", "", "<http://ctro/data#Publication_3702> <http://ctro/data#hasAuthor> \"Mastropasqua L\"."
1660, Author, 182, 191, "Carpineto", "", "<http://ctro/data#Publication_3702> <http://ctro/data#hasAuthor> \"Carpineto\"."
1656, Author, 196, 209, "Ciancaglini M", "", "<http://ctro/data#Publication_3702> <http://ctro/data#hasAuthor> \"Ciancaglini M\"."
1657, Author, 212, 223, "Gallenga PE", "", "<http://ctro/data#Publication_3702> <http://ctro/data#hasAuthor> \"Gallenga PE\"."
1664, Country, 338, 343, "Italy", "", 
1669, ObjectiveDescription, 358, 585, "To compare the efficacy and side effects and the effect on aqueous humor dynamics of 0 . 005 % latanoprost applied topically once daily with 0 . 5 % timolol given twice daily for 12 months to patients with pigmentary glaucoma .", "", "<http://ctro/data#ClinicalTrial_3712> <http://ctro/data#hasObjectiveDescription> \"To compare the efficacy and side effects and the effect on aqueous humor dynamics of 0 . 005 % latanoprost applied topically once daily with 0 . 5 % timolol given twice daily for 12 months to patients with pigmentary glaucoma .\"."
1799, DoseValue, 443, 450, "0 . 005", "", 
1800, Percentage, 451, 452, "%", "", 
1790, Latanoprost, 453, 464, "latanoprost", "", 
1792, Frequency, 483, 487, "once", "", 
1791, Interval, 488, 493, "daily", "", 
1802, DoseValue, 499, 504, "0 . 5", "", 
1801, Percentage, 505, 506, "%", "", 
1793, Timolol, 507, 514, "timolol", "", 
1794, Frequency, 521, 526, "twice", "", 
1795, Interval, 527, 532, "daily", "", 
1796, Duration, 537, 546, "12 months", "", "<http://ctro/data#Intervention_3826> <http://ctro/data#hasDuration> \"12 months\". <http://ctro/data#Intervention_3832> <http://ctro/data#hasDuration> \"12 months\"."
1798, Precondition, 550, 583, "patients with pigmentary glaucoma", "", 
1797, PigmentaryGlaucoma, 564, 583, "pigmentary glaucoma", "", 
1671, Randomized, 609, 619, "randomized", "", 
1672, DoubleBlind, 622, 637, "double - masked", "", 
1701, ClinicalTrial, 640, 654, "clinical study", "", 
1821, NumberPatientsCT, 672, 684, "Thirty - six", "", "<http://ctro/data#ClinicalTrial_3712> <http://ctro/data#hasNumberPatientsCT> \"Thirty - six\"."
1675, Precondition, 694, 798, "affected with bilateral pigmentary glaucoma controlled with no more than a single hypotensive medication", "", "<http://ctro/data#Population_3743> <http://ctro/data#hasPrecondition> \"affected with bilateral pigmentary glaucoma controlled with no more than a single hypotensive medication\"."
1674, PigmentaryGlaucoma, 718, 737, "pigmentary glaucoma", "", 
1702, Randomized, 869, 877, "randomly", "", 
1682, NumberPatientsArm, 935, 937, "18", "", "<http://ctro/data#Arm_3731> <http://ctro/data#hasNumberPatientsArm> \"18\". <http://ctro/data#Arm_3737> <http://ctro/data#hasNumberPatientsArm> \"18\"."
1687, DoseValue, 966, 973, "0 . 005", "", "<http://ctro/data#Medication_3838> <http://ctro/data#hasDoseValue> \"0 . 005\"."
1690, Percentage, 974, 975, "%", "", "<http://ctro/data#Medication_3838> <http://ctro/data#hasDoseUnit> <http://ctro/data#Percentage>."
1685, Latanoprost, 976, 987, "latanoprost", "", "<http://ctro/data#Latanoprost_3839> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Latanoprost>. <http://ctro/data#Medication_3838> <http://ctro/data#hasDrug> <http://ctro/data#Latanoprost_3839>."
1707, Eyedrops, 988, 996, "eyedrops", "", "<http://ctro/data#Medication_3838> <http://ctro/data#hasDeliveryMethod> <http://ctro/data#Eyedrops>."
1695, Frequency, 997, 1001, "once", "", "<http://ctro/data#Intervention_3826> <http://ctro/data#hasFrequency> \"once\"."
1692, Interval, 1002, 1007, "daily", "", "<http://ctro/data#Intervention_3826> <http://ctro/data#hasInterval> \"daily\"."
1676, Placebo, 1016, 1023, "vehicle", "", 
1681, Placebo, 1026, 1033, "placebo", "", 
1705, Frequency, 1036, 1040, "once", "", 
1706, Interval, 1041, 1046, "daily", "", 
1686, Timolol, 1073, 1080, "timolol", "", "<http://ctro/data#Medication_3844> <http://ctro/data#hasDrug> <http://ctro/data#Timolol>."
1688, DoseValue, 1081, 1086, "0 . 5", "", "<http://ctro/data#Medication_3844> <http://ctro/data#hasDoseValue> \"0 . 5\"."
1691, Percentage, 1087, 1088, "%", "", "<http://ctro/data#Medication_3844> <http://ctro/data#hasDoseUnit> <http://ctro/data#Percentage>."
1708, Eyedrops, 1089, 1097, "eyedrops", "", "<http://ctro/data#Medication_3844> <http://ctro/data#hasDeliveryMethod> <http://ctro/data#Eyedrops>."
1694, Frequency, 1098, 1103, "twice", "", "<http://ctro/data#Intervention_3832> <http://ctro/data#hasFrequency> \"twice\"."
1693, Interval, 1104, 1109, "daily", "", "<http://ctro/data#Intervention_3832> <http://ctro/data#hasInterval> \"daily\"."
1696, Diurnal_IOP, 1136, 1174, "Diurnal curves of intraocular pressure", "", "<http://ctro/data#Endpoint_3821> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#Diurnal_IOP>."
1699, IOP, 1177, 1180, "IOP", "", 
1710, Interval, 1198, 1257, "on the baseline day and after 0 . 5 , 3 , 6 , and 12 months", "", 
1709, IOP, 1277, 1280, "IOP", "", 
1711, Frequency, 1312, 1364, "8 : 00 AM , 12 : 00 noon , 4 : 00 PM , and 8 : 00 PM", "", 
1766, EndPointDescription, 1367, 1383, "Outflow facility", "", "<http://ctro/data#EndPointDescription_3820> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_3815> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_3820>."
1767, EndPointDescription, 1388, 1389, "C", "", 
1728, TimePoint, 1414, 1426, "baseline day", "", 
1722, TimePoint, 1434, 1459, "the last day of the study", "", 
1700, MeasurementDevice, 1467, 1495, "Schiotz electronic tonometer", "", "<http://ctro/data#MeasurementDevice_3819> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice>. <http://ctro/data#Endpoint_3815> <http://ctro/data#hasMeasurementDevice> <http://ctro/data#MeasurementDevice_3819>."
1730, CTAnalysisApproach, 1498, 1695, "A two - tailed Student ' s t test for paired or unpaired data was used for statistical evaluation of differences between treatment and baseline values or between the latanoprost and timolol group .", "", 
1741, Latanoprost, 1664, 1675, "latanoprost", "", 
1742, Timolol, 1680, 1687, "timolol", "", 
1723, Diurnal_IOP, 1696, 1707, "Diurnal IOP", "", 
1727, CTAnalysisApproach, 1696, 1749, "Diurnal IOP measurements were compared hour by hour .", "", "<http://ctro/data#CTAnalysisApproach_3726> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#CTAnalysisApproach>. <http://ctro/data#ClinicalTrial_3712> <http://ctro/data#hasAnalysisApproach> <http://ctro/data#CTAnalysisApproach_3726>."
1835, Mean, 1750, 1754, "Mean", "", "<http://ctro/data#Mean_3823> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_3821> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_3823>."
1724, CTAnalysisApproach, 1750, 1814, "Mean values of the two eyes IOP and   C   were used for analysis", "", "<http://ctro/data#CTAnalysisApproach_3717> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#CTAnalysisApproach>. <http://ctro/data#ClinicalTrial_3712> <http://ctro/data#hasAnalysisApproach> <http://ctro/data#CTAnalysisApproach_3717>."
1726, IOP, 1778, 1781, "IOP", "", 
1808, EndPointDescription, 1788, 1789, "C", "", 
1743, Latanoprost, 1870, 1881, "latanoprost", "", 
1745, Timolol, 1886, 1893, "timolol", "", 
1747, PValueBL, 1917, 1928, "P < 0 . 001", "", "<http://ctro/data#Outcome_3855> <http://ctro/data#hasPValueBL> \"P < 0 . 001\". <http://ctro/data#Outcome_3882> <http://ctro/data#hasPValueBL> \"P < 0 . 001\". <http://ctro/data#Outcome_3909> <http://ctro/data#hasPValueBL> \"P < 0 . 001\". <http://ctro/data#Outcome_3936> <http://ctro/data#hasPValueBL> \"P < 0 . 001\"."
1746, IOP, 1944, 1947, "IOP", "", 
1750, IOP, 2028, 2031, "IOP", "", 
1751, Reduction, 2036, 2041, "6 . 0", "", "<http://ctro/data#Outcome_3855> <http://ctro/data#hasChangeValue> \"6 . 0\"."
1838, SdErrorChangeValue, 2042, 2053, "+ / - 4 . 5", "", "<http://ctro/data#Outcome_3855> <http://ctro/data#hasSdErrorChangeValue> \"+ / - 4 . 5\"."
1752, Reduction, 2058, 2063, "5 . 9", "", "<http://ctro/data#Outcome_3882> <http://ctro/data#hasChangeValue> \"5 . 9\"."
1839, SdErrorChangeValue, 2064, 2075, "+ / - 4 . 6", "", "<http://ctro/data#Outcome_3882> <http://ctro/data#hasSdErrorChangeValue> \"+ / - 4 . 6\"."
1753, Latanoprost, 2081, 2092, "latanoprost", "", 
1754, Reduction, 2097, 2102, "4 . 8", "", "<http://ctro/data#Outcome_3909> <http://ctro/data#hasChangeValue> \"4 . 8\"."
1840, SdErrorChangeValue, 2103, 2114, "+ / - 3 . 0", "", "<http://ctro/data#Outcome_3909> <http://ctro/data#hasSdErrorChangeValue> \"+ / - 3 . 0\"."
1755, Reduction, 2119, 2124, "4 . 6", "", "<http://ctro/data#Outcome_3936> <http://ctro/data#hasChangeValue> \"4 . 6\"."
1841, SdErrorChangeValue, 2125, 2136, "+ / - 3 . 1", "", "<http://ctro/data#Outcome_3936> <http://ctro/data#hasSdErrorChangeValue> \"+ / - 3 . 1\"."
1756, Timolol, 2142, 2149, "timolol", "", 
1758, TimePoint, 2156, 2157, "6", "", 
1757, TimePoint, 2162, 2171, "12 months", "", 
1758, TimePoint, 2165, 2171, "months", "", 
1761, Latanoprost, 2234, 2245, "latanoprost", "", 
1762, Timolol, 2250, 2257, "timolol", "", 
1760, PvalueDiff, 2293, 2304, "P < 0 . 001", "", "<http://ctro/data#DiffBetweenGroups_3752> <http://ctro/data#hasPvalueDiff> \"P < 0 . 001\"."
1763, TimePoint, 2321, 2322, "3", "", 
1764, TimePoint, 2325, 2326, "6", "", 
1765, TimePoint, 2333, 2335, "12", "", 
1833, Mean, 2345, 2349, "Mean", "", "<http://ctro/data#Mean_3817> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_3815> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_3817>."
1768, EndPointDescription, 2352, 2353, "C", "", 
1809, RelativeIncrement, 2399, 2401, "30", "", "<http://ctro/data#Outcome_3963> <http://ctro/data#hasRelativeChangeValue> \"30\"."
1770, Latanoprost, 2418, 2429, "latanoprost", "", 
1769, PValueBL, 2475, 2486, "P = 0 . 017", "", "<http://ctro/data#Outcome_3963> <http://ctro/data#hasPValueBL> \"P = 0 . 017\"."
1834, Mean, 2491, 2495, "Mean", "", 
1771, ConjunctivalHyperemia, 2496, 2518, "conjunctival hyperemia", "", 
1810, PercentageAffected, 2533, 2538, "0 . 3", "", "<http://ctro/data#Outcome_3990> <http://ctro/data#hasPercentageAffected> \"0 . 3\"."
1772, Latanoprost, 2542, 2553, "latanoprost", "", 
1811, PercentageAffected, 2573, 2578, "0 . 2", "", "<http://ctro/data#Outcome_4017> <http://ctro/data#hasPercentageAffected> \"0 . 2\"."
1773, Timolol, 2582, 2589, "timolol", "", 
1836, ObservedResult, 2620, 2640, "change in iris color", "", "<http://ctro/data#Outcome_4044> <http://ctro/data#hasObservedResult> \"change in iris color\"."
1774, IrisPigmentation, 2620, 2640, "change in iris color", "", 
1812, NumberAffected, 2670, 2671, "1", "", "<http://ctro/data#Outcome_4044> <http://ctro/data#hasNumberAffected> \"1\"."
1778, FinalNumPatientsArm, 2679, 2681, "18", "", "<http://ctro/data#Arm_3731> <http://ctro/data#hasFinalNumPatientsArm> \"18\"."
1776, Latanoprost, 2704, 2715, "latanoprost", "", 
1779, FinalNumPatientsArm, 2732, 2734, "18", "", "<http://ctro/data#Arm_3737> <http://ctro/data#hasFinalNumPatientsArm> \"18\"."
1777, Timolol, 2757, 2764, "timolol", "", 
1780, IrisPigmentation, 2767, 2806, "Darkening of the peripheral iris stroma", "", 
1781, Latanoprost, 2850, 2861, "latanoprost", "", 
1782, Timolol, 2871, 2878, "timolol", "", 
1783, HeartRate, 2887, 2897, "heart rate", "", 
1785, BaseLineValue, 2929, 2931, "72", "", "<http://ctro/data#Outcome_4071> <http://ctro/data#hasBaselineValue> \"72\"."
1813, SdErrorBL, 2932, 2939, "+ / - 9", "", "<http://ctro/data#Outcome_4071> <http://ctro/data#hasSdErrorBL> \"+ / - 9\"."
1837, SdErrorResValue, 2958, 2966, "+ / - 10", "", "<http://ctro/data#Outcome_4071> <http://ctro/data#hasSdErrorResValue> \"+ / - 10\"."
1788, PulseRate, 2967, 2983, "beats per minute", "", 
1786, TimePoint, 2987, 2989, "12", "", "<http://ctro/data#Outcome_4071> <http://ctro/data#hasTimePoint> \"12\"."
1820, ConclusionComment, 3013, 3103, "Although further studies may need to confirm these data on a larger sample and to evaluate", "", "<http://ctro/data#ClinicalTrial_3712> <http://ctro/data#hasConclusionComment> \"Although further studies may need to confirm these data on a larger sample and to evaluate\"."
1818, ConclusionComment, 3104, 3352, "the side effect of increased iris pigmentation on long - term follow - up , in patients with pigmentary glaucoma , 0 . 005 % latanoprost taken once daily was well tolerated and more effective in reducing IOP than 0 . 5 % timolol taken twice daily .", "", "<http://ctro/data#ClinicalTrial_3712> <http://ctro/data#hasConclusionComment> \"the side effect of increased iris pigmentation on long - term follow - up , in patients with pigmentary glaucoma , 0 . 005 % latanoprost taken once daily was well tolerated and more effective in reducing IOP than 0 . 5 % timolol taken twice daily .\"."
1815, PigmentaryGlaucoma, 3197, 3216, "pigmentary glaucoma", "", 
1734, DoseValue, 3219, 3226, "0 . 005", "", 
1733, Percentage, 3227, 3228, "%", "", 
1732, Latanoprost, 3229, 3240, "latanoprost", "", 
3000, Frequency, 3247, 3257, "once daily", "", 
1737, IOP, 3308, 3311, "IOP", "", 
1739, DoseValue, 3317, 3322, "0 . 5", "", 
1740, Percentage, 3323, 3324, "%", "", 
1738, Timolol, 3325, 3332, "timolol", "", 
1816, Frequency, 3339, 3344, "twice", "", 
1817, Interval, 3345, 3350, "daily", "", 
1684, PMID, 3408, 3416, "10080213", "", "<http://ctro/data#Publication_3702> <http://ctro/data#hasPMID> \"10080213\"."
